(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 8.08% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 3.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Astrana Health's revenue in 2026 is $3,844,194,000.On average, 13 Wall Street analysts forecast ASTH's revenue for 2026 to be $227,463,382,608, with the lowest ASTH revenue forecast at $215,981,526,000, and the highest ASTH revenue forecast at $239,223,925,056. On average, 13 Wall Street analysts forecast ASTH's revenue for 2027 to be $249,368,089,632, with the lowest ASTH revenue forecast at $230,640,401,184, and the highest ASTH revenue forecast at $268,262,989,584.
In 2028, ASTH is forecast to generate $270,102,316,128 in revenue, with the lowest revenue forecast at $255,722,126,784 and the highest revenue forecast at $285,820,197,504.